Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$115.11 - $142.29 $71,828 - $88,788
-624 Reduced 22.76%
2,118 $257,000
Q2 2022

Aug 12, 2022

SELL
$112.71 - $135.93 $38,321 - $46,216
-340 Reduced 11.03%
2,742 $326,000
Q1 2022

May 13, 2022

BUY
$126.0 - $156.48 $8,064 - $10,014
64 Added 2.12%
3,082 $408,000
Q4 2021

Feb 11, 2022

BUY
$147.95 - $164.3 $10,504 - $11,665
71 Added 2.41%
3,018 $482,000
Q3 2021

Nov 12, 2021

SELL
$147.58 - $179.28 $46,487 - $56,473
-315 Reduced 9.66%
2,947 $464,000
Q2 2021

Aug 13, 2021

SELL
$127.69 - $148.81 $104,195 - $121,428
-816 Reduced 20.01%
3,262 $482,000
Q1 2021

May 14, 2021

SELL
$114.99 - $130.12 $17,133 - $19,387
-149 Reduced 3.52%
4,078 $518,000
Q4 2020

Feb 05, 2021

SELL
$100.01 - $119.3 $61,106 - $72,892
-611 Reduced 12.63%
4,227 $501,000
Q3 2020

Nov 06, 2020

SELL
$88.11 - $103.42 $4,669 - $5,481
-53 Reduced 1.08%
4,838 $488,000
Q2 2020

Aug 13, 2020

SELL
$68.92 - $91.14 $83,944 - $111,008
-1,218 Reduced 19.94%
4,891 $432,000
Q1 2020

May 14, 2020

BUY
$63.37 - $90.13 $12,547 - $17,845
198 Added 3.35%
6,109 $438,000
Q4 2019

Feb 14, 2020

SELL
$72.49 - $85.45 $1,449 - $1,709
-20 Reduced 0.34%
5,911 $504,000
Q3 2019

Nov 01, 2019

SELL
$65.59 - $78.07 $54,439 - $64,798
-830 Reduced 12.28%
5,931 $454,000
Q2 2019

Aug 02, 2019

BUY
$66.89 - $81.94 $452,243 - $553,996
6,761 New
6,761 $505,000
Q2 2018

Aug 10, 2018

SELL
$61.14 - $69.55 $736,737 - $838,077
-12,050 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$65.05 - $74.82 $2.93 Million - $3.37 Million
-45,050 Reduced 78.9%
12,050 $806,000
Q4 2017

Feb 02, 2018

SELL
$64.87 - $70.59 $3.91 Million - $4.26 Million
-60,300 Reduced 51.36%
57,100 $3.82 Million
Q3 2017

Nov 01, 2017

BUY
$58.57 - $66.17 $6.88 Million - $7.77 Million
117,400
117,400 $7.54 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.8B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.